M Caminati1, L Cegolon2, M Bacchini3, N Segala3, A Dama4, C Bovo5, B Olivieri6, F Furci7, G Senna1. 1. Department of Medicine, University of Verona, Verona, Italy. 2. Local Health Unit N.2 "Marca Trevigiana", Public Health Department, Treviso, Italy. l.cegolon@gmail.com. 3. Pharmacists' Association of Verona, Verona, Italy. 4. Asthma Centre & Allergy Unit, Verona University Hospital, Verona, Italy. 5. Medical Directorate, Verona University Hospital, Verona, Italy. 6. Residency Programme in Allergy & Clinical Immunology, Verona University Hospital, Verona, Italy. 7. Department of Clinical & Experimental Medicine, University Hospital G. Martino, Messina, Italy.
Abstract
BACKGROUND: Asthma control and monitoring still represents a challenge worldwide. Although the international guidelines suggest the interplay between secondary and primary care services as an effective strategy to control the disease, community pharmacies' are seldom involved in asthma control assessment. The present cross-sectional study aimed at providing a picture of the relationship between asthma severity and control in community pharmacies within the health district of the city of Verona (Veneto Region, North-Eastern Italy). METHODS: A call for participation was launched through the Pharmacists' Association of Verona. Patients referring to the participating pharmacies with an anti-asthmatic drug medical prescription and an asthma exemption code were asked to complete the Asthma Control Test (ACT) and a brief questionnaire collecting information on their age, sex, smoking status, aerobic physical exercise and usual asthma therapy, which also defined asthma severity. A multinomial logistic regression model was fitted to investigate the risk of uncontrolled as well as poorly controlled vs. controlled asthma (base). Results were expressed as relative risk ratios (RRR) with 95% confidence interval (95%CI). RESULTS: Fifty-seven community pharmacies accepted to participate and 584 asthmatic patients (54% females; mean-age: 51 ± 19 years) were consecutively recruited from 1st January to 30th June 2018 (6 months). Based upon ACT score 50.5% patients had a controlled asthma, 22.3% a poorly controlled and 27.2% uncontrolled. A variable proportion of patients with uncontrolled asthma were observed for every level of severity, although more frequently with mild persistent form of asthma. Most patients (92%) self-reported regular compliance with therapy. At multinomial regression analysis, patients under regular asthma treatment course (RRR = 0.33; 95%CI: 0.15; 0.77) were less likely to have an ACT< 16 compared to those not taking medications regularly. CONCLUSIONS: Overall, our findings highlighted an unsatisfactory asthma control in the general population, independently of the severity level of the disease. Community pharmacies could be a useful frontline interface between patients and the health care services, supporting an effective asthma management plan, from disease assessment and monitoring treatment compliance to referral of patients to specialist medical consultancies.
BACKGROUND:Asthma control and monitoring still represents a challenge worldwide. Although the international guidelines suggest the interplay between secondary and primary care services as an effective strategy to control the disease, community pharmacies' are seldom involved in asthma control assessment. The present cross-sectional study aimed at providing a picture of the relationship between asthma severity and control in community pharmacies within the health district of the city of Verona (Veneto Region, North-Eastern Italy). METHODS: A call for participation was launched through the Pharmacists' Association of Verona. Patients referring to the participating pharmacies with an anti-asthmatic drug medical prescription and an asthma exemption code were asked to complete the Asthma Control Test (ACT) and a brief questionnaire collecting information on their age, sex, smoking status, aerobic physical exercise and usual asthma therapy, which also defined asthma severity. A multinomial logistic regression model was fitted to investigate the risk of uncontrolled as well as poorly controlled vs. controlled asthma (base). Results were expressed as relative risk ratios (RRR) with 95% confidence interval (95%CI). RESULTS: Fifty-seven community pharmacies accepted to participate and 584 asthmatic patients (54% females; mean-age: 51 ± 19 years) were consecutively recruited from 1st January to 30th June 2018 (6 months). Based upon ACT score 50.5% patients had a controlled asthma, 22.3% a poorly controlled and 27.2% uncontrolled. A variable proportion of patients with uncontrolled asthma were observed for every level of severity, although more frequently with mild persistent form of asthma. Most patients (92%) self-reported regular compliance with therapy. At multinomial regression analysis, patients under regular asthma treatment course (RRR = 0.33; 95%CI: 0.15; 0.77) were less likely to have an ACT< 16 compared to those not taking medications regularly. CONCLUSIONS: Overall, our findings highlighted an unsatisfactory asthma control in the general population, independently of the severity level of the disease. Community pharmacies could be a useful frontline interface between patients and the health care services, supporting an effective asthma management plan, from disease assessment and monitoring treatment compliance to referral of patients to specialist medical consultancies.
Entities:
Keywords:
Asthma; Asthma control test; Community pharmacies; Control; Treatment compliance
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Dianne P Goeman; Rosalie A Aroni; Susan M Sawyer; Kay Stewart; Francis C K Thien; Michael J Abramson; Jo A Douglass Journal: Med J Aust Date: 2004-02-02 Impact factor: 7.738
Authors: Andrea Vianello; Marco Caminati; Mariangiola Crivellaro; Rafi El Mazloum; Rossella Snenghi; Michele Schiappoli; Annarita Dama; Andrea Rossi; Giuliana Festi; Maria Rita Marchi; Chiara Bovo; Giorgio Walter Canonica; Gianenrico Senna Journal: World Allergy Organ J Date: 2016-12-14 Impact factor: 4.084
Authors: Sara R A Wijnant; Lies Lahousse; Marc L De Buyzere; Guy G Brusselle; Ernst R Rietzschel Journal: J Clin Med Date: 2019-07-28 Impact factor: 4.241
Authors: Barbara Putman; Louise Coucke; Anna Vanoverschelde; Els Mehuys; Lies Lahousse Journal: BMC Health Serv Res Date: 2022-01-26 Impact factor: 2.655